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license (http://creativecommons.org/Summary This paper describes degradation and cellematerial interaction studies on hydroxy-
apatite (HA)-coated biodegradable porous iron proposed for hard tissue scaffolds. Porous iron
scaffolds are expected to serve as an ideal platform for bone regeneration. To couple their
inherentmechanical strength, pureHA andHA/poly(ε-caprolactone) (HA/PCL)were coated onto
porous iron using dip coating technique. TheHA/PCLmixturewas prepared to provide amore sta-
ble and flexible coating than HA alone. Degradation of the samples was evaluated by weight loss
and potentiodynamic polarisation. Human skin fibroblast (HSF) and human mesenchymal stem
cells (hMSC) were put in contact with the samples and their interaction was observed. Results
showed that coated samples degraded w10 times slower (0.002 mm/year for HA/PCL-Fe,
0.003 mm/year for HA-Fe) than the uncoated ones (0.031 mm/year), indicating an inhibition ef-
fect of the coating on degradation. Both HSF and hMSCmaintained high viability when in contact
with the coated samples (100e110% control for hMSC during 2e5 days of incubation), indicating
the effect of HA in enhancing cytocompatibility of the surface. This study provided early evi-
dence of the potential translation of biodegradable porous iron scaffolds for clinical use in ortho-
pedic surgery. However, further studies including in vitro and in vivo tests are necessary.
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Bone scaffolds have been used to facilitate the regenera-
tion of new bone tissues and maintain a balance between
temporary mechanical support, degradation, and cell
growth. Separate from the widely chosen polymers, porous
biodegradable metals have recently been viewed as po-
tential materials for hard tissue scaffolds [1]. The inherent
strength and ductility owned by metals are the key features
that make them more appealing than polymers for hard
tissue applications. Biodegradable metal scaffolds have
shown interesting mechanical properties, especially
Young’s modulus and toughness, which are close to that of
human bone with tailored degradation behaviour. For
instance, the Young’s modulus of magnesium (Mg;
41e45 GPa) is closer to that of cortical bone [2]. Despite
having higher mechanical properties in fully dense state,
(i.e., Young’s modulusZ 211 GPa), pure iron (Fe) strengths
can be rendered having mechanical properties closer to
those of bone by altering its porosity. Porous iron-
ephosphorus (FeeP) alloys fabricated through powder
metallurgy have resulted in an elastic modulus of 2.3 GPa,
which is comparable to that of typical bone [3,4] More
recently, porous pure Fe with a pore size of 450 um and 88%
porosity exhibited a compressive strength of 0.33 MPa that
falls within the range of cancellous bone strength [5e8]. In
essence, the porosity and pore sizes of the porous biode-
gradable metals can be altered to obtain desired mechan-
ical properties, degradation behaviour, and cellematerial
interaction. In addition, the porosity must be inter-
connected to provide spaces for osteogenesis while main-
taining optimum mechanical properties of the scaffolds [9].
Mg and its alloys are the most studied biodegradable
metals and the recent coating technology has enable Mg to
have a more controllable degradation rate suitable for bone
scaffold applications [10e14]. The porous structure of Mg
has been proven to play a significant role in cell growth and
proliferation [15,16]. Meanwhile, porous Fe was introduced
much more recently [8,17,18]. The in vitro cytotoxicity test
on three types of porous Fe manufactured by replication
method, FeeMg, Fe, and Fe-carbon nanotubes, has shown
proliferation of osteoblastic cells [18] and the degradation
product of Fe was proven to be nontoxic to endothelial cells
[19]. Despite its appealing in vitro cytocompatibility, the
inherent high strength of Fe will easily provide the required
initial strength of the scaffolds to stabilize the affected
bone. Compared to Mg or polymeric scaffolds, higher
strength of Fe will allow more flexible control on the porous
structure to meet specific bone strength requirements
[1,18].
Cell attachment, migration, differentiation, and prolif-
eration in the porous structure are among the important
cellematerial interaction parameters that determine the
suitability of a material for scaffolds. Starting with cell
attachment, an attractive-to-cell surface should be pre-
pared. Hydroxyapatite (HA) is a well-known bioactive
ceramic material having similar chemical composition to
human bone and has excellent bone bonding ability [20].
The use of HA coatings on metallic implants have been
reported to stimulate faster bone cell attachment, result-
ing in an improvement healing rate and bone strengthduring the early stage of implantation [21,22]. However, HA
alone is brittle and to overcome this issue, a coating of HA
and poly(ε-caprolactone) (PCL) composite was proposed.
This resulted in a more stable and flexible coating without
cracking or delamination compared with the single HA
coating [23]. This study will be the first to investigate
cellematerial interaction as valid evidence to propose HA-
coated porous biodegradable iron as novel bone scaffolds.
Samples of pure porous Fe, HA-coated porous Fe, and HA/
PCL-coated porous Fe were tested for degradation and
bioactivity. The interaction of human skin fibroblast
(HSF1184) and human mesenchymal stem cells (hMSC) on
the coated and uncoated samples were observed. Static
immersion (weight loss) and potentiodynamic polarisation
(PDP) tests were performed to investigate the degradation
behaviour.
Materials and methods
Sample preparation
Interconnected-pores porous pure-Fe sheets (purity 99.9%,
pore size Z 450 mm, porosity Z 88%) were kindly provided
by Alantum Corporation, Korea. According to the manu-
facturer, the porous pure-Fe sheet was made via the poly-
mer space holder method. Samples of the porous pure-Fe
(10 mm  10 mm  1.6 mm) were coated with hydroxy-
apatite (HA, SigmaeAldrich, USA) and composite of hy-
droxyapatite/poly(ε-caprolactone) (HA/PCL) using a dip
coating method (Dip Coater PTL-MMB, MTI Corp, USA) to
produce HA-coated porous Fe (HA-Fe) and HA/PCL-coated
porous Fe (HA/PCL-Fe), respectively. The HA suspension
were prepared by dissolving crystalline micro-HA powders
in methanol at 10% weight/volume ratio at room temper-
ature and homogeneously stirred for 72 hours. PCL pellets
(Mw Z 65,000, SigmaeAldrich) and HA powders (1:1 ratio)
were dissolved in chloroform at 15% weight/volume ratio
and then homogeneously stirred for 72 hours. The dip
coating process was performed at a constant withdraw and
down speeds of 200 mm/minute five times, and the coated
samples were let to cure at room temperature for 24 hours
[24]. Microstructure and surface morphology of the samples
were analysed by a scanning electron microscope (SEM,
Hitachi TM3000, Japan) coupled with energy-dispersive X-
ray spectroscopy (EDX, SwiftED 3000, Oxford Instruments,
UK).
Degradation tests
Static immersion test were carried out in minimum essen-
tial medium solution (MEM, Gibco, Australia) similarly used
for cell culture medium. Three samples of pure-Fe, HA-Fe,
and HA/PCL-Fe were immersed in 100 mL MEM at 37C for 7
days, 14 days, and 21 days in a CO2 incubator. Weight of the
samples was measured prior to and after the immersion
test. The samples were rinsed in deionized water and
ethanol and brushed gently as specified by the American
Society for Testing and Materials (ASTM) G1-03 standard
[25] followed by air and vacuum drying for 48 hours to
completely remove all degradation products prior to
weighing. Some samples were incubated for 25 days and
Hydroxyapatite-coated biodegradable porous iron 1795 mL of eluates were then taken out and tested for Fe ion
concentration using an inductively-coupled plasma mass
spectrometry (ICP-MS, PerkinElmer, USA).
PDP testing was carried out using a potentiostat (Ver-
sastat 3, Princeton Applied Research, USA) on the same
samples as for immersion but using simulated body fluid
(SBF), as suggested by Kokubo and Takadama [26], as the
electrolyte solution at room temperature. The three elec-
trodes system was used where graphite, Ag/AgCl (KCl
3.5M), and the samples served as the counter, reference,
and working electrodes, respectively. Samples with 1 cm2
exposed area were stabilized for 5 minutes at their open
circuit potential (OCP) prior to the test. Tafel curve was
scanned at a range of 0.25 V versus the Ecorr with a rate of
1.666 mV/s.
Cellematerial interaction evaluation
Three cellematerial interaction parameters (cell viability,
attachment, and morphology) were evaluated. HSF 1184
(European Collection of Cell Culture, UK) and hMSC cells
(ScienCell Research Labs, USA) were used. Three groups of
samples (pure-Fe, HA-Fe, and HA/PCL-Fe) were cleaned in
sterile phosphate buffered saline (PBS) containing 10% an-
tibiotics (100 U/100 mg/mL penicillin/streptomycin), rinsed
with a flow of sterile water, and autoclaved at 120C for 20
minutes as final sterilisation steps [27]. The HSF cells were
cultured in a MEM supplemented with 10% (v/v) fetal bovine
serum (FBS) (Gibco), together with 1% antibiotics. The hMSC
cells were cultured in a mesenchymal stem cell medium
(MSCm, ScienCell Research Labs) supplemented with 25 mL
FBS, 5 mL Pen/strep, and 10 mL of mesenchymal stem cell
growth supplement (MCGS, ScienCell Research Labs) pro-
ducing 500 mL complete medium. Cultures were incubated
in a humidified atmosphere containing 5% CO2 at 37C.
As much as 2  105 cells/mL of HSF and 5  104 cells/mL
of hMSC were seeded on the samples in a 12-well plate
using direct method assay according to the ASTM F813
standard [28]. The viability of the cell toward sample was
measured after 24 hours of incubation and was assessed by
trypan blue exclusion test whereas metabolic activity were
determined based on MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium] assay after 2 days, 3 days, and 5
days. Cell attachment on the sample surfaces was evalu-
ated under a fluorescence microscope (Fluoview FV1000,
Olympus, USA) using HSF cells prepared the same way as for
cell viability. The adhered HSF cell was detached byFigure 1 Surface morphology of fabricated samples: (A) pur
HA Z hydroxyapatite; PCL Z poly (ε-caprolactone).trypsinization and further staining by acridine orange/pro-
pidium iodide (AO/PI, SigmaeAldrich). The PI identifies
dead cells by giving off a red colour whereas the AO, which
is permeable to live cells, identifies live cells by its green
colour [29]. For cell morphology evaluation, the samples
were seeded with 1  105 cells/mL concentrated number of
hMSC, incubated for 2 hours in a 5% CO2 humidified atmo-
sphere at 37C. Then, 2 mL medium was added to each well
and incubated for 48 hours. The samples were withdrawn
from the culture plate and washed with PBS, fixed with
2.5% glutaraldehyde for 1 hour, dehydrated sequentially in
50%, 70%, 90% and 100% ethanol for 10 minutes each and
observed under the SEM.
All results were expressed as mean  standard deviation
(SD) of three replicates. Statistical analysis was done using
SigmaPlot (Systat Software, San Jose, USA) and Student t-
test for multiple comparisons. The level of significance was
determined when p < 0.05.Results
Coating characterisation
Fig. 1 shows surface morphology of the pure-Fe, HA-Fe, and
HA/PCL-Fe samples. HA and HA/PCL deposits are both
evidently seen to cover the Fe struts and some pores as
well. As measured by the EDX, the deposits were composed
of 51.6 wt% O, 5.7 wt% P, 4.5 wt% Ca, 38.3 wt% Fe for HA-
Fe, and 36.1 wt% O, 2.9 wt% P, 5.1 wt% Ca, and 8.8 wt%
Fe for HA/PCL-Fe. Both coatings are characterized by a
rough and embossed surface, whereas HA were sparsely
embedded in the PCL phase.Degradation test
Fig. 2A shows weight loss of the samples after immersion in
MEM at different time period. The weight loss of pure-Fe
and HA-Fe increased until 14 days and decreased at 21
days. Fig. 2B shows weight loss and Fe ion release of the
samples after 25 days of immersion. The HA-Fe sample
exhibited the highest weight loss with 32.79% followed by
the pure-Fe and HA/PCL-Fe samples which were 8.07% and
2.53% respectively. Fe ion concentration was found higher
in the media of pure-Fe sample than those of HA/PCL-Fe
and HA-Fe samples.e Fe, (B) HA-Fe, and (C) HA/PCL-Fe samples. Fe Z iron;
Figure 2 Weight loss of the samples are shown. (A) In minimum essential medium solution for different immersion times. (B)
After 25 days’ immersion and its corresponding iron ion release.
Figure 3 Potentiodynamic polarisation curves of the
samples.
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from the potentiodynamic polarisation tests in SBF. The
pure-Fe sample shows active, passive, and transpassive
corrosion behaviours that were not observed in both coated
samples. The coating could have acted as a barrier for
anodic dissolution, hence slowing down the formation of a
passive layer. Higher overpotentials were required to break
down the HA/PCL and HA coating. An interesting phenom-
enon was observed for the HA-Fe sample that rendered an
OCP to be approximately 200 mV more cathodic compared
to the HA/PCL-Fe and pure-Fe. This may indicate that the
HA/PCL coating created a less noble surface toward
corrosion in SBF at the early stage of degradation. Overall,
as depicted in the Tafel curves, pure-Fe sample possesses
the highest current density (whighest degradation rate),Table 1 Degradation rate of the pure-Fe, HA-Fe, and HA/
PCL-Fe samples.
Parameter HA/PCL-Fe HA-Fe Pure-Fe
Ecorr (mV) 643 835 650
Icorr (A/cm
2) 0.20E-6 0.27E-6 0.26E-5
Degradation rate (mm/y) 0.002 0.003 0.031
Fe Z iron; HA Z hydroxyapatite; PCL Z poly(ε-caprolactone).whereas current densities of HA-Fe and HA/PCL-Fe are
almost comparable. Table 1 details degradation/corrosion
parameters calculated by Tafel extrapolation. It can be
seen that the coated samples degraded about 10 times
slower (0.002 mm/year for HA/PCL-coated, 0.003 mm/year
for HA-coated) than the uncoated ones (0.031 mm/year).
Cellematerial interaction observation
Fig. 4 shows viability of HSF 1184 and hMSC cultured with
the samples at Day 2, Day 3, and Day 5. A significantFigure 4 Cell viability. (A) Human skin fibroblast 1184 cells.
(B) Human mesenchymal stem cells cultured with the samples
at Day 2, Day 3, and Day 5 (n Z 3). *p < 0.05. **p > 0.05.
FeZ iron; HAZ hydroxyapatite; PCLZ poly(ε-caprolactone).
Hydroxyapatite-coated biodegradable porous iron 181decrease (p < 0.05) of HSF cell viability is observed for
pure-Fe and HA-Fe groups (Fig. 4A). Meanwhile, HA/PCL-Fe
group maintained higher cell viability at all incubation pe-
riods than the other groups. The high cell viability of all
groups after 2 days of incubation indicates that Fe ion
concentration had no influence on the cell’s metabolic
activity.
Fig. 5 shows fluorescent images of HSF cells detached
from the surface of samples. Cells were observed on the
surface of pure-Fe sample as indicated by white arrows
(Fig. 5A). The blue arrows indicate cells that were not well
stained and some cells were lysed as exposed to the
corrosion product on the HA-Fe sample (Fig. 5B). The
aggregated and clump cells were also observed on the
surface of HA/PCL-Fe sample as indicated by yellow arrows
(Fig. 5C).
Fig. 6 shows SEM images of the hMSC seeded and incu-
bated on the samples for 72 hours. There is no obvious
change on the morphology and distribution of cells
observed on pure-Fe (Fig. 6A and B) and HA/PCL-Fe samples
(Fig. 6E and F). The hMSCs grew well on the surfaces of HA-
Fe (Fig. 6C and D). The cells developed an extended filo-
podia and long pseudopods as observed on the cell mem-
brane. The cell size enlarged, indicating spread to the HA-
Fe surface.Discussion
Coating characteristic and degradation behaviour
Porous iron was proposed for hard tissue scaffolds and its
potentiality was evaluated in the current study. Porous
pure Fe, and HA-coated and HA/PCL-coated porous pure Fe
samples were compared for their degradation and
cellematerial interaction behaviours. From morphological
observation (Fig. 1), the overall porosity of both samples
was not significantly affected because the coating homo-
geneously coats the metal struts and no blockage in the
pores was observed. The interconnected pores are impor-
tant for cell migration and proliferation because they have
been studied for osteoblasts and mesenchymal stem cells as
well as for vascular formation [30]. However, detail coating
characterisation (thickness, adherence, etc.) was not done
in this work because the work was focused more on
cellematerial interactions.Figure 5 Human skin fibroblast cells detached from the follow
Fe Z iron; HA Z hydroxyapatite; PCL Z poly(ε-caprolactone).The coated samples experienced the lowest degradation
rate than the uncoated ones as determined by ion release
measurement and PDP (Figs. 2 and 3). The decrease in the
degradation rate by coating can be related to the accu-
mulation of phosphate products from the HA and MEM, as
detected by the EDX. This is consistent with a phosphating
treatment study, which observed corrosion inhibition of Mg
samples by phosphate deposition [31], and this effect could
also be prominent for Fe samples [32]. Furthermore, the
surface of pure-Fe and HA-Fe samples were covered by a
brownish hydroxide layer that prevented direct contact of
Fe struts with the solution or impeded the diffusion of Fe
ions [33]. The EDX result on the layer composed of 51.6 wt%
O and 38.3 wt% Fe. The dissolution of iron in any simulated
body fluid could form ferrous hydroxide, Fe(OH)3. The low
weight loss of the HA/PCL-Fe sample could be attributed to
the slowly degrading PCL because of its hydrophobic char-
acter and high crystallinity [34]. The addition of HA parti-
cles into PCL further decreased the degradation rate of PCL
by partial neutralisation of the acidic degradation acidic
by-product [35]. An in vivo study has demonstrated that the
degradation time of the HA/PCL composite extended to >2
years [36]. However, the degradation rate determination by
weight loss may cause bias because it also counted the
weight loss of the coating. Therefore, Fe ion release was
measured (Fig. 2B). As the immersion test was prolonged,
the media became more alkaline (pH > 8) and in this con-
dition Fe2þ transforms to Fe3þ and forms solid Fe(OH)3. This
reaction should be more pronounced in the media of the
HA-Fe sample, resulting in lesser Fe ion concentration
detected by the ICP-MS.Cellematerial interaction
Viability of HSF cells decreased when in contact with the
samples as incubation time was prolonged, and hMSC cells
maintained its viability over the incubation periods (Fig. 4).
With the prolonged incubation, Fe ion concentration
increased thereby lowered HSF cells’ survival. The static
condition of incubation retained the toxic degradation
product in contact with the HSF cells. A dynamic cell cul-
ture could increase cell proliferation because of a constant
supply of fresh medium and removal of toxic degradation
product [37]. Meanwhile, the viability of hMSC in response
to the samples shows more positive results than those of
HSF cells results. The hMSC maintained their viability ating surfaces: (A) pure-Fe, (B) HA/PCL-Fe, (C) HA-Fe samples.
Figure 6 Morphologies of hMSC cells before and after 3 days’ incubation. (A, B) Pure Fe sample. (C, D) HA-Fe sample. (E, F) HA/
PCL-Fe sample. Fe Z iron; HA Z hydroxyapatite; PCL Z poly(ε-caprolactone).
182 N. Mohd Daud et al.100% versus control up to 5 days incubation (Fig. 4B). Sta-
tistical analysis indicates that the cell proliferation on the
HA-Fe group was significantly higher than other groups
(p < 0.05) after 1 day of incubation with hMSC and 5 days of
incubation with HSF cells. The release of calcium and
phosphate from the dissolved HA affects the proliferation
and metabolic activities of the cells. This is consistent with
a study done by Li et al [38] that showed better cyto-
compatibility of osteoblast on iron (III) doped HA using the
wet chemical method.
Both cells were observed to preferably attach and grow
actively on the coated surfaces, especially on the HA-
coated surface (Fig. 5). This observation showed that a
number of cells were well adhered to bioactive porous
surfaces. Bioactive materials are capable to form bonds
through bone-like HA layers and biological collagen with
material surface in physiological fluid. Within 2 days of
culture, the cell density on the surfaces was significant,suggesting that the coated porous surfaces had favourable
biological properties [39]. Furthermore, the MSC preferred
to align on the HA-coated surface indicated by its growing
filopodia (Fig. 6). This could be related to the surface
wettability of HA-Fe sample because HA is known for its
strong hydrophilicity [40]. The hydrophilicity of the HA-Fe
surface may have fallen within the optimal wettability
range that is good for cell adhesion [41]. Overall, the
bioactivity of iron was attained by HA coating. This work
provides early evidence of the potentiality of HA-coated
porous Fe to be used as bone scaffolds. Some potential
applications include bone defect repair and cancerous bone
treatment, especially when the coating is loaded with
anticancer drugs. However, further investigations should be
performed to give more information on biocompatibility
such as more in vitro and in vivo cytotoxicity of this Fe-
based porous scaffold. Iron is known as essential for the
fundamental biological process of cells and body and is
Hydroxyapatite-coated biodegradable porous iron 183beneficial for many enzymes and the main component of
hemoglobin. Its degradability and high ductility makes Fe
preferable for biodegradable stent and has shown positive
results in a study using rabbits [42]. However, excess Fe can
be deleterious to the human body because it can induce the
formation of reactive oxygen intermediate by a series of
processes that eventually may lead to various pathological
conditions such as neurodegenerative disease [43]. More-
over, not much information is available on bone-related
iron toxicity.
Conclusion
HA-coated porous Fe was proposed for hard tissue scaffolds
and its potentiality was evaluated in the current study. HA-
coated and HA/PCA samples were found to degrade slower
than the uncoated ones, indicating the inhibiting effect of
the coating on degradation process. HSF and hMSC were
found to maintain high viability when in contact with the
coated samples indicating the effect of hydroxyapatite in
enhancing cytocompatibility of the surface. Moreover, the
hMSC preferred to attach on the HA-coated samples indi-
cated by the filopodia formation. Finally, this study pro-
vided evidence of the early cytocompatibility of porous Fe,
and further studies will focus on its characterisation for
hard tissue replacement. The authors confirm that there
are no known conflicts of interest associated with this
publication and there has been no significant financial
support for this work that could have influenced its
outcome.
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